Company profile ADAP
After 39 days of this quarter the interest is at 162.0. Based on that we can calculate that during remaining 52 days it will total up to 378.0. Adaptimmune expected interest is significantly higher compared to previous quarter (+53.7%) and same quarter last year (+83.5%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 145 | 281 93.8% QoQ | 249 -11.4% QoQ | 191 -23.3% QoQ |
| 2020 | 310 113.8% YoY 62.3% QoQ | 443 57.7% YoY 42.9% QoQ | 250 0.4% YoY -43.6% QoQ | 220 15.2% YoY -12.0% QoQ |
| 2021 | 215 -30.6% YoY -2.3% QoQ | 166 -62.5% YoY -22.8% QoQ | 285 14.0% YoY 71.7% QoQ | 173 -21.4% YoY -39.3% QoQ |
| 2022 | 187 -13.0% YoY 8.1% QoQ | 224 34.9% YoY 19.8% QoQ | 160 -43.9% YoY -28.6% QoQ | 260 50.3% YoY 62.5% QoQ |
| 2023 | 206 10.2% YoY -20.8% QoQ | 151 -32.6% YoY -26.7% QoQ | 199 24.4% YoY 31.8% QoQ | 246 -5.4% YoY 23.6% QoQ |
| 2024 | 162 -21.4% YoY -34.1% QoQ | - | - | - |
The average 5 years interest of Adaptimmune was 18.1 per week. The last year interest of Adaptimmune compared to the last 5 years has changed by -4.25%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -13.87%.
After 39 days of this quarter the interest is at 85.0. Based on that we can calculate that during remaining 52 days it will total up to 198.0. Adaptimmune Therapeutics expected interest is significantly higher compared to previous quarter (+94.1%) and same quarter last year (+83.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 198 inf% QoQ | 104 -47.5% QoQ | 231 122.1% QoQ |
| 2020 | 156 inf% YoY -32.5% QoQ | 323 63.1% YoY 107.1% QoQ | 192 84.6% YoY -40.6% QoQ | 223 -3.5% YoY 16.1% QoQ |
| 2021 | 123 -21.2% YoY -44.8% QoQ | 88 -72.8% YoY -28.5% QoQ | 165 -14.1% YoY 87.5% QoQ | 24 -89.2% YoY -85.5% QoQ |
| 2022 | 106 -13.8% YoY 341.7% QoQ | 197 123.9% YoY 85.8% QoQ | 93 -43.6% YoY -52.8% QoQ | 57 137.5% YoY -38.7% QoQ |
| 2023 | 108 1.9% YoY 89.5% QoQ | 56 -71.6% YoY -48.1% QoQ | 139 49.5% YoY 148.2% QoQ | 102 78.9% YoY -26.6% QoQ |
| 2024 | 85 -21.3% YoY -16.7% QoQ | - | - | - |
The average 5 years interest of Adaptimmune Therapeutics was 10.61 per week. The last year interest of Adaptimmune Therapeutics compared to the last 5 years has changed by -23.0%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -31.34%.
There is not enough data for Adaptimmune cancer therapy to provide analysis
There is not enough data for Adaptimmune cancer therapy to provide correlation calculation
There is not enough data for Adaptimmune cancer therapy to provide analysis
There is not enough data for Adaptimmune clinical trials to provide analysis
There is not enough data for Adaptimmune clinical trials to provide correlation calculation
There is not enough data for Adaptimmune clinical trials to provide analysis
There is not enough data for Adaptimmune Research to provide analysis
There is not enough data for Adaptimmune Research to provide correlation calculation
There is not enough data for Adaptimmune Research to provide analysis
There is not enough data for Adaptimmune careers to provide analysis
There is not enough data for Adaptimmune careers to provide correlation calculation
There is not enough data for Adaptimmune careers to provide analysis
There is not enough data for Adaptimmune reviews to provide analysis
There is not enough data for Adaptimmune reviews to provide correlation calculation
There is not enough data for Adaptimmune reviews to provide analysis
There is not enough data for Adaptimmune UK to provide analysis
There is not enough data for Adaptimmune UK to provide correlation calculation
There is not enough data for Adaptimmune UK to provide analysis
There is not enough data for Adaptimmune US to provide analysis
There is not enough data for Adaptimmune US to provide correlation calculation
There is not enough data for Adaptimmune US to provide analysis
After 39 days of this quarter the interest is at 114.0. Based on that we can calculate that during remaining 52 days it will total up to 266.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 120 | 317 164.2% QoQ | 276 -12.9% QoQ | 228 -17.4% QoQ |
| 2020 | 334 178.3% YoY 46.5% QoQ | 335 5.7% YoY 0.3% QoQ | 297 7.6% YoY -11.3% QoQ | 273 19.7% YoY -8.1% QoQ |
| 2021 | 208 -37.7% YoY -23.8% QoQ | 240 -28.4% YoY 15.4% QoQ | 220 -25.9% YoY -8.3% QoQ | 225 -17.6% YoY 2.3% QoQ |
| 2022 | 259 24.5% YoY 15.1% QoQ | 326 35.8% YoY 25.9% QoQ | 202 -8.2% YoY -38.0% QoQ | 275 22.2% YoY 36.1% QoQ |
| 2023 | 316 22.0% YoY 14.9% QoQ | 279 -14.4% YoY -11.7% QoQ | 323 59.9% YoY 15.8% QoQ | 219 -20.4% YoY -32.2% QoQ |
| 2024 | 114 -63.9% YoY -47.9% QoQ | - | - | - |
The average 5 years interest of Adaptimmune -stock -company was 20.64 per week. The last year interest of Adaptimmune -stock -company compared to the last 5 years has changed by 7.17%. The interest for Adaptimmune -stock -company is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 2.17%.